Documents
The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial
Frederich Robert, Mcneill Robert, Berglind Niklas, Fleming Douglas, Chen Roland, Chen
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
{{productCategoryLabel}}
{{productTitle}}
{{productAuthors}}
{{productCategoryLabel}}
{{productThemeLabel}}
{{productTitle}}
{{productAuthors}}
{{productPages}}
{{productLanguageIsoCode}}